We are live on ! Find out more
SKYE icon

Skye Bioscience
SKYE

39 hedge funds and large institutions have $9.91M invested in Skye Bioscience in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less ownership

Funds ownership: 50.32% → 48.32% (-2%)

18% less capital invested

Capital invested by funds: $12.1M → $9.91M (-$2.18M)

22% less funds holding

Funds holding: 50 → 39 (-11)

36% less call options, than puts

Call options by funds: $25K | Put options by funds: $39K

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

Holders
39
Holders Change
-11
Holders Change %
-22%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
9
Reduced
8
Closed
14
Calls
$25K
Puts
$39K
Net Calls
-$14K
Net Calls Change
-$53K

Top Buyers

1
SFM
Sphera Funds Management
Israel
+$163K
2
BBA
Baker Bros. Advisors
New York
+$102K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$54.7K
4
UBS Group
UBS Group
Switzerland
+$26.5K
5
BlackRock
BlackRock
New York
+$3.5K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$99.6K
2
SSA
Schonfeld Strategic Advisors
New York
-$70K
3
Two Sigma Investments
Two Sigma Investments
New York
-$21.2K
4
HF
HRT Financial
New York
-$20K
5
Jane Street
Jane Street
New York
-$18.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
26
Zurich Cantonal Bank
Switzerland
$32 – – –
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$31 – – –
Rockefeller Capital Management
28
Rockefeller Capital Management
New York
$24 – – –
Optiver Holding
29
Optiver Holding
Netherlands
$12 – – –
CA
30
CoreCap Advisors
Michigan
$5 – – –
PMFA
31
Plante Moran Financial Advisors
Michigan
$2 – – –
NFSG
32
Newbridge Financial Services Group
Florida
$1 -$14 -17 -94%
HI
33
Harbour Investments
Wisconsin
$1 – – –
MCA
34
McGuire Capital Advisors
Oklahoma
$1 – – –
PP
35
PFS Partners
New Jersey
$1 – – –
IA
36
IFP Advisors
Florida
$1 +$1 +1 +100%
LHEI
37
Leo H. Evart Inc
California
$1 +$1 +1 New
Citigroup
38
Citigroup
New York
$1 +$2 +2 New
SSA
39
Schonfeld Strategic Advisors
New York
– -$70K -93,407 Closed
Two Sigma Advisers
40
Two Sigma Advisers
New York
– -$30.7K -40,982 Closed
HF
41
HRT Financial
New York
– -$20K -27,348 Closed
Jane Street
42
Jane Street
New York
– -$18.5K -24,615 Closed
GCP
43
GSA Capital Partners
United Kingdom
– -$17K -22,877 Closed
RS
44
R Squared
Hong Kong
– -$11.1K -14,782 Closed
CAI
45
Capital Advisors Inc
Oklahoma
– -$7.5K -10,000 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$5.16K -6,331 Closed
Fidelity Investments
47
Fidelity Investments
Massachusetts
– -$561 -748 Closed
Bank of America
48
Bank of America
North Carolina
– -$438 -586 Closed
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
– -$382 -510 Closed
FFO
50
Fortitude Family Office
Arizona
– -$289 -385 Closed
1
2
3

SKYE Hedge Fund Activity: Q1 2026 in Review

39 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q1 2026, worth a combined $9.91M — down 18% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SKYE and 5 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Sphera Funds Management, adding an estimated $163K. The largest seller was Millennium Management, cutting an estimated $99.6K.

  • 39 institutional investors held Skye Bioscience (SKYE) as of Q1 2026, down from 50 in Q4 2025.
  • Funds reported $9.91M of Skye Bioscience stock for Q1 2026, down 18% quarter-over-quarter.
  • 5 funds opened new Skye Bioscience positions in Q1 2026 and 14 closed out, a net change of -9 holders.
  • The largest Skye Bioscience buyer in Q1 2026 was Sphera Funds Management, an estimated $163K added.
  • The largest Skye Bioscience seller in Q1 2026 was Millennium Management, an estimated $99.6K sold.

Based on aggregated 13F filings for Q1 2026.